Sierra Oncology
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $94,585,000.

Profit Margin

Sierra Oncology, Inc. (NASDAQ:SRRA): Profit margin
2013 0 -6.83M
2014 0 -23.87M
2015 0 -53.26M
2016 0 -47.86M
2017 0 -42.01M
2018 0 -53.33M
2019 0 -88.27M
2020 300K -80.90M -26967.33%
2021 0 -94.65M

SRRA Income Statement (2013 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
0300K0000000
Cost of revenue
000000000
Gross profit
0300K0000000
Operating exp.
Research and development
67.15M45.11M53.24M41.07M30.15M33.89M26.35M19.07M2.84M
Selling and marketing
000000000
Total operating expenses
94.58M65.24M66.99M55.41M42.61M48.07M35.82M22.57M4.00M
Operating income
-94.66M-64.94M-66.99M-55.41M-42.61M-48.07M-35.82M-22.57M-4.00M
Other income (expenses), net
0-15.81M-21.44M1.78M760K351K-17.37M-1.29M-2.82M
Income before tax
-94.66M-80.76M-88.43M-53.63M-41.85M-47.72M-53.20M-23.87M-6.83M
Income tax expense
-3K142K-160K-302K156K143K55K2K-108K
Net income
-94.65M-80.90M-88.27M-53.33M-42.01M-47.86M-53.26M-23.87M-6.83M
Earnings per share
Basic EPS
-7.14-7.7-30.3-30.16-33.68-63.32-147.95-56.76-13.19
Diluted EPS
-7.14-7.7-30.3-30.16-33.68-63.32-147.95-56.76-13.19
Data sourceData sourceData sourceData sourceData sourceData sourceData source